GB2068944A - Chemical compound - Google Patents
Chemical compound Download PDFInfo
- Publication number
- GB2068944A GB2068944A GB8101518A GB8101518A GB2068944A GB 2068944 A GB2068944 A GB 2068944A GB 8101518 A GB8101518 A GB 8101518A GB 8101518 A GB8101518 A GB 8101518A GB 2068944 A GB2068944 A GB 2068944A
- Authority
- GB
- United Kingdom
- Prior art keywords
- general formula
- compounds
- represent
- chemical compound
- ulcerstatic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 22
- 230000000694 effects Effects 0.000 claims abstract description 7
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 3
- 229910052801 chlorine Inorganic materials 0.000 claims abstract description 3
- 125000001309 chloro group Chemical group Cl* 0.000 claims abstract description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims abstract description 3
- 150000007522 mineralic acids Chemical class 0.000 claims abstract 2
- 150000007524 organic acids Chemical class 0.000 claims abstract 2
- 150000003839 salts Chemical class 0.000 claims abstract 2
- 238000000034 method Methods 0.000 claims description 5
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 4
- 238000010992 reflux Methods 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 2
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims 3
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims 2
- 230000029936 alkylation Effects 0.000 claims 2
- 238000005804 alkylation reaction Methods 0.000 claims 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 239000012442 inert solvent Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract description 2
- 239000000460 chlorine Substances 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 6
- 238000001816 cooling Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 3
- 239000003610 charcoal Substances 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 238000010908 decantation Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- AKMNUCBQGHFICM-UHFFFAOYSA-N 1-(2-methyl-1,3-benzoxazol-6-yl)-3-(1,5-naphthyridin-4-yl)urea Chemical compound C1=CN=C2C(NC(=O)NC3=CC=C4N=C(OC4=C3)C)=CC=NC2=C1 AKMNUCBQGHFICM-UHFFFAOYSA-N 0.000 description 1
- RMBZFWLMYVPNGI-UHFFFAOYSA-N 11-(2-chloroacetyl)-5h-pyrido[2,3-b][1,4]benzodiazepin-6-one Chemical compound O=C1NC2=CC=CN=C2N(C(=O)CCl)C2=CC=CC=C21 RMBZFWLMYVPNGI-UHFFFAOYSA-N 0.000 description 1
- FFYTTYVSDVWNMY-UHFFFAOYSA-N 2-Methyl-5-nitroimidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1 FFYTTYVSDVWNMY-UHFFFAOYSA-N 0.000 description 1
- LXBGSDVWAMZHDD-UHFFFAOYSA-N 2-methyl-1h-imidazole Chemical compound CC1=NC=CN1 LXBGSDVWAMZHDD-UHFFFAOYSA-N 0.000 description 1
- -1 5,11-dihydro-11-(2'-methylimidazol-1-yl-acetyl)-6H-pyrido-[2,3-b] [1,4]-benzodiazepin-6-one 5,1-dihydro-11-chloroacetyl-6H-pyrido-[2,3-b] [1,4]-benzodiazepin-6-one Chemical compound 0.000 description 1
- MIRBIZDDMSFTKY-UHFFFAOYSA-N 5,11-dihydropyrido[2,3-b][1,4]benzodiazepin-6-one Chemical class O=C1NC2=CC=CN=C2NC2=CC=CC=C12 MIRBIZDDMSFTKY-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 206010042220 Stress ulcer Diseases 0.000 description 1
- JPKKQJKQTPNWTR-KQAYXBCTSA-N [(1r,5s)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] (2r)-3-hydroxy-2-phenylpropanoate;sulfuric acid;hydrate Chemical compound O.OS(O)(=O)=O.C1([C@H](CO)C(=O)OC2C[C@H]3CC[C@@H](C2)N3C)=CC=CC=C1.C1([C@H](CO)C(=O)OC2C[C@H]3CC[C@@H](C2)N3C)=CC=CC=C1 JPKKQJKQTPNWTR-KQAYXBCTSA-N 0.000 description 1
- JDQJWBCSXZWVGM-UHFFFAOYSA-N acetonitrile;2-propan-2-yloxypropane Chemical compound CC#N.CC(C)OC(C)C JDQJWBCSXZWVGM-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 239000000538 analytical sample Substances 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- QYETZOYLEWPRIX-UHFFFAOYSA-N pyrido[2,3-b][1,4]benzodiazepin-6-one Chemical class O=C1N=C2C=CC=NC2=NC2=CC=CC=C12 QYETZOYLEWPRIX-UHFFFAOYSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 1
- JVBXVOWTABLYPX-UHFFFAOYSA-L sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT19423/80A IT1193371B (it) | 1980-01-24 | 1980-01-24 | 11-(2'-imidazol-1''-il)-acetil-5,11-diidro-6h-pirido 2,3-b 1,4 benzodiazepin-6-oni,metodo per la loro preparazione e la loro applicazione nella terapia dell'ulcera |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB2068944A true GB2068944A (en) | 1981-08-19 |
Family
ID=11157749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB8101518A Withdrawn GB2068944A (en) | 1980-01-24 | 1981-01-19 | Chemical compound |
Country Status (13)
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4210648A (en) * | 1977-05-31 | 1980-07-01 | Boehringer Ingelheim Gmbh | II-Aminoacyl-5,11-dihydro-6H-pyrido(2,3-B) (1,4)benzodiazepin-6-ones and salts thereof |
-
1979
- 1979-01-22 GR GR63939A patent/GR72993B/el unknown
-
1980
- 1980-01-24 IT IT19423/80A patent/IT1193371B/it active
-
1981
- 1981-01-14 BE BE0/203478A patent/BE887069A/fr unknown
- 1981-01-19 GB GB8101518A patent/GB2068944A/en not_active Withdrawn
- 1981-01-21 SE SE8100333A patent/SE8100333L/xx not_active Application Discontinuation
- 1981-01-22 YU YU00169/81A patent/YU16981A/xx unknown
- 1981-01-23 ZA ZA00810510A patent/ZA81510B/xx unknown
- 1981-01-23 DK DK32481A patent/DK32481A/da unknown
- 1981-01-23 JP JP889481A patent/JPS56113783A/ja active Pending
- 1981-01-23 FR FR8101328A patent/FR2474501A1/fr active Pending
- 1981-01-23 PT PT72392A patent/PT72392B/pt unknown
- 1981-01-23 DE DE19813102152 patent/DE3102152A1/de not_active Withdrawn
- 1981-01-23 ES ES498768A patent/ES8201157A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| SE8100333L (sv) | 1981-07-25 |
| PT72392A (en) | 1981-02-01 |
| FR2474501A1 (fr) | 1981-07-31 |
| IT8019423A0 (it) | 1980-01-24 |
| YU16981A (en) | 1983-10-31 |
| ZA81510B (en) | 1982-05-26 |
| ES498768A0 (es) | 1981-12-01 |
| DE3102152A1 (de) | 1981-12-10 |
| BE887069A (fr) | 1981-05-04 |
| DK32481A (da) | 1981-07-25 |
| ES8201157A1 (es) | 1981-12-01 |
| PT72392B (en) | 1981-12-21 |
| IT1193371B (it) | 1988-06-15 |
| GR72993B (enrdf_load_stackoverflow) | 1984-01-25 |
| JPS56113783A (en) | 1981-09-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3006097C2 (enrdf_load_stackoverflow) | ||
| Anderson et al. | Synthesis and antileukemic activity of 5-substituted 2, 3-dihydro-6, 7-bis (hydroxymethyl)-1H-pyrrolizine diesters | |
| IE47363B1 (en) | Imidazole derivatives | |
| CA1257271A (en) | 6-vinyl-furo-(3,4-c)-pyridine derivatives | |
| EA005377B1 (ru) | ТЕТРАГИДРОИМИДАЗО [1,2-h][1,7] НАФТИРИДИНОВЫЕ СОЕДИНЕНИЯ | |
| GB2104522A (en) | Tetrazine derivatives | |
| CA1108138A (en) | Triazine derivatives | |
| SU583758A3 (ru) | Способ получени производных 1,4-диазепина или их солей | |
| FI67697C (fi) | Foerfarande foer framstaellning av farmakologiskt vaerdefulla i 5-staellning substituerade 5,10-dihydro-11h-dibenzo-(b,e)(1,4)diazepin-11-oner | |
| US4213985A (en) | Novel 5,11-dihydro-6H-pyrido-[2,3-b][1,4]-benzodiazepine-6-ones | |
| GB2068944A (en) | Chemical compound | |
| HK24194A (en) | Pyrrolo[1,2-a][4,1]benzoxazepines, process for their preparation, pharmaceutical compositions containing these compounds and therapeutical use | |
| EP0491814B1 (en) | Tetracyclic imidazoquinazoline derivatives, preparation and pharmaceutical compositions | |
| EP1150983A1 (en) | Triazolo-pyridazine derivatives as ligands for gaba receptors | |
| CA1314885C (en) | Tricyclic derivatives which are agonists of cholinergic receptors, and drugs in which they are present | |
| CA1154766A (en) | Antiallergic nitrogen bridgehead compounds and process for the preparation thereof | |
| CA1212945A (en) | S-triazolo¬1,5-a|-pyrimidine derivatives | |
| US4968792A (en) | Psychotropic benzisothiazole derivatives | |
| EP0320910B1 (en) | 2-Thiazolidinone derivatives, pharmaceutical compositions containing them, process for preparing same, and use | |
| PL91000B1 (en) | Process for the manufacture of indole derivatives [gb1407658a] | |
| US3759933A (en) | 3h-imidazo(4,5-c)pyridines | |
| DE3225386A1 (de) | Substituierte naphthyl-imidazo (4,5-b) pyridine, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen | |
| Valpuesta et al. | Regio‐and Stereoselective Stevens Rearrangement of Benzyltetrahydroprotoberberinium Salts | |
| SU797580A3 (ru) | Способ получени производных изохино-лиНА, иХ СОлЕй, РАцЕМАТОВ или ОпТичЕС-КиХ изОМЕРОВ | |
| CA1134363A (en) | Pyrano-heterocycles, process for preparing them and medicaments containing these compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |